Attorney General Todd Rokita is calling on Hoosiers to check their eligibility for compensation for certain generic drug purchases after the U.S. District Court for the District of Connecticut granted preliminary approval of a plan to distribute settlement funds from manufacturers accused of conspiring to inflate generic drug prices.
Attorney General Rokita’s office and a coalition of 47 other states and territories previously announced settlements with Glenmark, Lannett, Bausch, Apotex, Heritage, and Heritage’s parent company, Emcure, totaling approximately $96.5 million. The distribution plan aims to return millions of those dollars to consumers potentially harmed by the elevated prices.
“Hoosiers deserve fair pricing for their medications, and we will not tolerate illegal schemes that drive up costs and harm consumers,” Attorney General Rokita said. “We continue holding Big Pharma accountable when they harm Hoosiers by putting profits over people. I encourage anyone who purchased these generic drugs to see if they’re eligible for compensation.”
If you purchased a generic drug listed here between May 2009 and December 2019, you may be eligible for compensation. To determine your eligibility, call 1-866-290-0182 (toll-free), email info@AGGenericDrugs.com, or visit www.AGGenericDrugs.com.
Lucerne man arrested on child solicitation charges claimed it was a social experiment
Logansport facility to close, loss of 95 jobs
Gov. Braun urges veterans to claim property tax relief before January deadline
Gas prices falling across Indiana
Caston School Corporation receives planning grant to research programs that hinder student success
Culver will be flushing hydrants beginning Monday
